Intensity Therapeutics, Inc. (INTS)
4.23
-0.02
(-0.47%)
USD |
NASDAQ |
Aug 31, 12:20
Intensity Therapeutics 1 Year Total Returns (Daily) : -41.58% for Aug. 28, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 28, 2026 | -41.58% |
| August 27, 2026 | -43.42% |
| August 26, 2026 | -39.98% |
| August 25, 2026 | -37.22% |
| August 24, 2026 | -37.52% |
| August 21, 2026 | -38.11% |
| August 20, 2026 | -34.93% |
| August 19, 2026 | -42.74% |
| August 18, 2026 | -44.61% |
| August 17, 2026 | -43.67% |
| August 14, 2026 | -46.93% |
| August 13, 2026 | -44.83% |
| August 12, 2026 | -43.36% |
| August 11, 2026 | -37.78% |
| August 10, 2026 | -36.42% |
| August 07, 2026 | -33.97% |
| August 06, 2026 | -37.66% |
| August 05, 2026 | -42.66% |
| August 04, 2026 | -37.05% |
| August 03, 2026 | -28.70% |
| July 31, 2026 | -40.07% |
| July 30, 2026 | -46.90% |
| July 29, 2026 | -46.04% |
| July 28, 2026 | -46.15% |
| July 27, 2026 | -43.75% |
| Date | Value |
|---|---|
| July 24, 2026 | -45.23% |
| July 23, 2026 | -44.62% |
| July 22, 2026 | -42.80% |
| July 21, 2026 | -44.72% |
| July 20, 2026 | -42.15% |
| July 17, 2026 | -43.03% |
| July 16, 2026 | -39.75% |
| July 15, 2026 | -41.86% |
| July 14, 2026 | -41.85% |
| July 13, 2026 | -40.90% |
| July 10, 2026 | -39.55% |
| July 09, 2026 | -36.48% |
| July 08, 2026 | -32.46% |
| July 07, 2026 | -32.53% |
| July 06, 2026 | -38.73% |
| July 02, 2026 | -43.47% |
| July 01, 2026 | -46.14% |
| June 30, 2026 | -46.58% |
| June 29, 2026 | -49.56% |
| June 26, 2026 | -46.41% |
| June 25, 2026 | -44.45% |
| June 24, 2026 | -45.60% |
| June 23, 2026 | -46.31% |
| June 22, 2026 | -43.18% |
| June 18, 2026 | -50.85% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 280.1% |
| Oncolytics Biotech, Inc. | -19.94% |
| Sangamo Therapeutics, Inc. | -70.35% |
| Sarepta Therapeutics, Inc. | 13.74% |
| Anixa Biosciences, Inc. | 15.61% |